Perfil
Adolf Hoess is currently the Chief Executive Officer at Affimed GmbH and SomaServe Ltd. He is also the Chairman-Management Board at Affimed NV Niederlassung Deutschland.
Previously, he held the position of Chief Executive Officer & Director at Affimed NV from 2010 to 2024.
He was also the Chief Executive Officer at Jenowis AG and Director at Amphivena Therapeutics, Inc. Dr. Hoess has a background in academia, having worked as a Principal at Harvard University in 1993.
He also served as the Vice President-Licensing & Business Development at MorphoSys AG and General Manager & VP-Molecular Division at Carl Zeiss Jena GmbH.
Additionally, he held the position of Chief Commercial Officer at Shire Orphan Therapies GmbH.
Dr. Hoess obtained his doctorate degrees from Technische Universität München in 1997 and Ludwig-Maximilians-Universität München in 1991.
Cargos activos de Adolf Hoess
| Empresas | Cargo | Inicio |
|---|---|---|
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Director Ejecutivo | - |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Director Ejecutivo | 01/09/2011 |
SomaServe Ltd.
SomaServe Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Director Ejecutivo | 01/10/2024 |
Antiguos cargos conocidos de Adolf Hoess.
| Empresas | Cargo | Fin |
|---|---|---|
| AFFIMED N.V. | Director Ejecutivo | 15/01/2024 |
Carl Zeiss Jena GmbH
Carl Zeiss Jena GmbH Medical SpecialtiesHealth Technology Manufactures lenses for health care, photography, projecting and research services | Corporate Officer/Principal | 01/01/2002 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1993 |
Jenowis AG | Director Ejecutivo | - |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Director/Miembro de la Junta | - |
Formación de Adolf Hoess.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 12 |
|---|---|
Affimed NV
Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Carl Zeiss Jena GmbH
Carl Zeiss Jena GmbH Medical SpecialtiesHealth Technology Manufactures lenses for health care, photography, projecting and research services | Health Technology |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Health Technology |
Jenowis AG | |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
SomaServe Ltd.
SomaServe Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
- Bolsa de valores
- Insiders
- Adolf Hoess
















